Company intelligence / Profile preview

Vitascale

Ownership: Private
Development stage: Commercial

Overview

Vitascale has developed and commercialized non-invasive breath-based diagnostic devices for real-time health analysis. Their technology is used for the diagnosis and monitoring of conditions such as diabetes, lung function, metabolism disorders, food intolerances, and nutrition status. The company emphasizes affordability and accessibility in preventive healthcare.

Therapeutic areas: PulmonologyEndocrinologyMetabolic DisordersGastroenterology
Modalities: DeviceNon-pharmacological therapy (breath analysis technology)
Industry: Metabolite Diagnostics

Partnerships

No major pharmaceutical or biotech partnerships disclosed in public sources.

Beyond the preview

Go deeper on Vitascale.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vitascale.

Explore the full profile